Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus

Gissette Reyes-Soffer, Steve Holleran, Marco R. Di Tullio, Shunichi Homma, Bernadette Boden-Albala, Rajasekhar Ramakrishnan, Mitchell S. Elkind, Ralph L Sacco, Henry N. Ginsberg

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The goal of this study was to determine if individuals with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) had greater endothelial dysfunction (ED) than individuals with only CAD. Flow-mediated dilation (FMD), calculated as percentage increase in brachial artery diameter in response to postischemic blood flow, was measured after an overnight fast in 2 cohorts. The first cohort included 76 participants in the Northern Manhattan Study with CAD; 25 also had T2DM. The second cohort was composed of 27 individuals with both T2DM and CAD who were participants in a study of postprandial lipemia. Combined, we analyzed 103 patients with CAD: 52 with T2DM (T2DM+) and 51 without T2DM (T2DM-). The 52 CAD T2DM+ subjects had a mean FMD of 3.9% ± 3.2%, whereas the 51 CAD T2DM- subjects had a greater mean FMD of 5.5% ± 4.0% (P < .03). An investigation of various confounders known to affect FMD identified age and body mass index as the only significant covariates in a multiple regression model. Adjusting for age and body mass index, we found that FMD remained lower in T2DM+ subjects compared with T2DM- subjects (difference, -1.99%; P < .03). In patients with CAD, the concomitant presence of T2DM is independently associated with greater ED, as measured by FMD. This finding may be relevant to the greater early and late morbidity and mortality observed in patients with both CAD and T2DM.

Original languageEnglish
Pages (from-to)1365-1371
Number of pages7
JournalMetabolism: Clinical and Experimental
Volume59
Issue number9
DOIs
StatePublished - Sep 1 2010
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Coronary Artery Disease
Dilatation
Body Mass Index
Brachial Artery
Hyperlipidemias
Morbidity

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Reyes-Soffer, G., Holleran, S., Di Tullio, M. R., Homma, S., Boden-Albala, B., Ramakrishnan, R., ... Ginsberg, H. N. (2010). Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus. Metabolism: Clinical and Experimental, 59(9), 1365-1371. https://doi.org/10.1016/j.metabol.2009.12.023

Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus. / Reyes-Soffer, Gissette; Holleran, Steve; Di Tullio, Marco R.; Homma, Shunichi; Boden-Albala, Bernadette; Ramakrishnan, Rajasekhar; Elkind, Mitchell S.; Sacco, Ralph L; Ginsberg, Henry N.

In: Metabolism: Clinical and Experimental, Vol. 59, No. 9, 01.09.2010, p. 1365-1371.

Research output: Contribution to journalArticle

Reyes-Soffer, G, Holleran, S, Di Tullio, MR, Homma, S, Boden-Albala, B, Ramakrishnan, R, Elkind, MS, Sacco, RL & Ginsberg, HN 2010, 'Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus', Metabolism: Clinical and Experimental, vol. 59, no. 9, pp. 1365-1371. https://doi.org/10.1016/j.metabol.2009.12.023
Reyes-Soffer, Gissette ; Holleran, Steve ; Di Tullio, Marco R. ; Homma, Shunichi ; Boden-Albala, Bernadette ; Ramakrishnan, Rajasekhar ; Elkind, Mitchell S. ; Sacco, Ralph L ; Ginsberg, Henry N. / Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus. In: Metabolism: Clinical and Experimental. 2010 ; Vol. 59, No. 9. pp. 1365-1371.
@article{1bffaf779c504512be28951164488962,
title = "Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus",
abstract = "The goal of this study was to determine if individuals with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) had greater endothelial dysfunction (ED) than individuals with only CAD. Flow-mediated dilation (FMD), calculated as percentage increase in brachial artery diameter in response to postischemic blood flow, was measured after an overnight fast in 2 cohorts. The first cohort included 76 participants in the Northern Manhattan Study with CAD; 25 also had T2DM. The second cohort was composed of 27 individuals with both T2DM and CAD who were participants in a study of postprandial lipemia. Combined, we analyzed 103 patients with CAD: 52 with T2DM (T2DM+) and 51 without T2DM (T2DM-). The 52 CAD T2DM+ subjects had a mean FMD of 3.9{\%} ± 3.2{\%}, whereas the 51 CAD T2DM- subjects had a greater mean FMD of 5.5{\%} ± 4.0{\%} (P < .03). An investigation of various confounders known to affect FMD identified age and body mass index as the only significant covariates in a multiple regression model. Adjusting for age and body mass index, we found that FMD remained lower in T2DM+ subjects compared with T2DM- subjects (difference, -1.99{\%}; P < .03). In patients with CAD, the concomitant presence of T2DM is independently associated with greater ED, as measured by FMD. This finding may be relevant to the greater early and late morbidity and mortality observed in patients with both CAD and T2DM.",
author = "Gissette Reyes-Soffer and Steve Holleran and {Di Tullio}, {Marco R.} and Shunichi Homma and Bernadette Boden-Albala and Rajasekhar Ramakrishnan and Elkind, {Mitchell S.} and Sacco, {Ralph L} and Ginsberg, {Henry N.}",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.metabol.2009.12.023",
language = "English",
volume = "59",
pages = "1365--1371",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus

AU - Reyes-Soffer, Gissette

AU - Holleran, Steve

AU - Di Tullio, Marco R.

AU - Homma, Shunichi

AU - Boden-Albala, Bernadette

AU - Ramakrishnan, Rajasekhar

AU - Elkind, Mitchell S.

AU - Sacco, Ralph L

AU - Ginsberg, Henry N.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - The goal of this study was to determine if individuals with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) had greater endothelial dysfunction (ED) than individuals with only CAD. Flow-mediated dilation (FMD), calculated as percentage increase in brachial artery diameter in response to postischemic blood flow, was measured after an overnight fast in 2 cohorts. The first cohort included 76 participants in the Northern Manhattan Study with CAD; 25 also had T2DM. The second cohort was composed of 27 individuals with both T2DM and CAD who were participants in a study of postprandial lipemia. Combined, we analyzed 103 patients with CAD: 52 with T2DM (T2DM+) and 51 without T2DM (T2DM-). The 52 CAD T2DM+ subjects had a mean FMD of 3.9% ± 3.2%, whereas the 51 CAD T2DM- subjects had a greater mean FMD of 5.5% ± 4.0% (P < .03). An investigation of various confounders known to affect FMD identified age and body mass index as the only significant covariates in a multiple regression model. Adjusting for age and body mass index, we found that FMD remained lower in T2DM+ subjects compared with T2DM- subjects (difference, -1.99%; P < .03). In patients with CAD, the concomitant presence of T2DM is independently associated with greater ED, as measured by FMD. This finding may be relevant to the greater early and late morbidity and mortality observed in patients with both CAD and T2DM.

AB - The goal of this study was to determine if individuals with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) had greater endothelial dysfunction (ED) than individuals with only CAD. Flow-mediated dilation (FMD), calculated as percentage increase in brachial artery diameter in response to postischemic blood flow, was measured after an overnight fast in 2 cohorts. The first cohort included 76 participants in the Northern Manhattan Study with CAD; 25 also had T2DM. The second cohort was composed of 27 individuals with both T2DM and CAD who were participants in a study of postprandial lipemia. Combined, we analyzed 103 patients with CAD: 52 with T2DM (T2DM+) and 51 without T2DM (T2DM-). The 52 CAD T2DM+ subjects had a mean FMD of 3.9% ± 3.2%, whereas the 51 CAD T2DM- subjects had a greater mean FMD of 5.5% ± 4.0% (P < .03). An investigation of various confounders known to affect FMD identified age and body mass index as the only significant covariates in a multiple regression model. Adjusting for age and body mass index, we found that FMD remained lower in T2DM+ subjects compared with T2DM- subjects (difference, -1.99%; P < .03). In patients with CAD, the concomitant presence of T2DM is independently associated with greater ED, as measured by FMD. This finding may be relevant to the greater early and late morbidity and mortality observed in patients with both CAD and T2DM.

UR - http://www.scopus.com/inward/record.url?scp=77956638398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956638398&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2009.12.023

DO - 10.1016/j.metabol.2009.12.023

M3 - Article

C2 - 20102776

AN - SCOPUS:77956638398

VL - 59

SP - 1365

EP - 1371

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 9

ER -